Hematology & Oncology

Adolescent and Young Adult Cancer Program at University Hospital Brings Care and Support to a Population in Need

Underserved cancer patients get their own space and medical team at San Antonio’s University Hospital.


Study: Gemcitabine Helps Prevent Recurrence of Low-Grade Bladder Cancer

A multi-institution clinical trial involving researchers from UT Health San Antonio shows significantly lower recurrence of bladder cancer in patients who received the chemotherapy drug gemcitabine.


UT Health San Antonio: Advancing Cancer Care For San Antonio

On Sept. 5, 2018, the UT Health San Antonio MD Anderson Cancer Center hosted a roundtable discussion with esteemed cancer leaders from UT Health San Antonio and MD Anderson Cancer Center to talk about the impact of cancer in San Antonio and how collaboration in patient care and research is essential to improving not only the outcomes for patients, but how creating a streamlined system of care using proven protocols and processes can best support families and caregivers. These thought leaders and clinicians walked through the rising incidence of the disease in San Antonio. They also laid out plans for how their work together will positively impact patients and their families while focusing on overall cost or “value” of health care spend for this disease that strikes aging and Hispanic populations disproportionately.


Treating Cancer, Healing People

As evidence mounts for the importance of addressing cancer’s hidden effects, Methodist Healthcare is building on a decades-old history of pioneering holistic cancer care in San Antonio and south Texas.


Solving the Thrombocytopenia Puzzle with Immature Platelet Testing

New advances in hematology testing offer parameters useful in assessing challenging conditions such as thrombocytopenia. The immature platelet fraction (IPF) is an available parameter on analyzers in some laboratories. When used with patient information and platelet counts, the IPF can help the clinician with the differential diagnosis of thrombocytopenia.